AbbVie

News mentioning AbbVie · Wikidata · RSS

Top stories

1. AbbVie Inc. $ABBV Shares Sold by CX Institutional2 outlets · 2026-10-02 23:54 UTC

Latest

1. Eli Lilly (LLY) and AbbVie (ABBV) Are Expanding Their Pipelines. Their Valuations Tell Two Different Storiesinsidermonkey.com · 2026-10-03 04:19 UTC · story
2. CX Institutional Cuts Stock Position in AbbVie Inc. $ABBVdailypolitical.com · 2026-10-02 23:54 UTC · 1 more reports
3. AbbVie Stock: Buy, Sell, or Hold in October?aol.com · 2026-09-30 16:50 UTC · story
4. AbbVie To Present New Dermatology Data At 2026 EADV Congressfinanzen.ch · 2026-09-30 14:55 UTC · story
5. BofA Boosts AbbVie and J&J Price Targets on Growth and Pipeline Strength247wallst.com · 2026-09-30 11:15 UTC · story
6. AbbVie Presents Detailed Phase 1 Data for ABBV-295, a Long-Acting Amylin Analog, Demonstrating Favorable Tolerability and Pharmacokinetic Profile at EASD 2026prnewswire.com · 2026-09-30 10:08 UTC · story
7. AbbVie Highlights Positive Results from the Phase 2 APEX Part B Study of Zumilokibart in Moderate to Severe Atopic Dermatitis, as a Late Breaker at EADV 2026prnewswire.com · 2026-09-30 07:14 UTC · story
8. AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congressprnewswire.com · 2026-09-30 05:40 UTC · story
9. Can AbbVie's Backing Help ADARx Win Over Biotech IPO Investors at a $1.74 Billion Valuation?insidermonkey.com · 2026-09-28 20:08 UTC · story
10. AbbVie Wins FDA Approval For JUVMO In Parkinson's Diseaserttnews.com · 2026-09-28 16:18 UTC · 1 more reports
11. AbbVie wants to include a Crohn's disease pill in the public health systempox.globo.com · 2026-09-28 14:01 UTC · story
    
12. STAT+: AbbVie wins FDA nod for Parkinson’s pillstatnews.com · 2026-09-28 13:40 UTC · story
    
13. AbbVie's Once-Daily Parkinson's Pill Juvmo Wins FDA Approval, with Nausea, Dizziness, and Headache Common in Trialsmedicaldaily.com · 2026-09-28 10:15 UTC · story
14. AbbVie Parkinson's disease drug 'Zuvmo' approved in the US... targeting both early and advanced patientscdn.medipana.com · 2026-09-27 22:30 UTC · story